Abstract:To investigate the effect of ALA intake on blood lipid profiles, including triglycerides (TG), total cholesterol (TC), high-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), very-low-density lipoprotein (VLDL-C) and ratio of TC to HDL-C. We systematically searched randomized controlled trials of ALA intervention on PubMed, Embase, Cochrane library and related references up to March 2018. The final values were calculated as weighted mean difference (WMD) by using a random effects model. Subgroup analysis and meta-regression were used to explore the source of heterogeneity. Generalized least square was performed for dose-response analysis. Forty-seven studies with 1305 individuals in the ALA arm and 1325 individuals in the control arm were identified. Compared with control group, dietary intake of ALA significantly reduced the concentrations of TG (WMD -0.101 mmol/L; 95% CI: -0.158 to -0.044 mmol/L;P = 0.001), TC (WMD -0.140 mmol/L; 95% CI: -0.224 to -0.056 mmol/L;P = 0.001), LDL-C (WMD -0.131 mmol/L; 95% CI: -0.191 to -0.071 mmol/L;P < 0.001), VLDL-C (WMD -0.121 mmol/L; 95% CI: -0.170 to -0.073 mmol/L;P < 0.001), TC/HDL-C ratio (WMD -0.165 mmol/L; 95% CI: -0.317 to -0.013 mmol/L;P = 0.033) and LDL-C/HDL-C ratio (WMD -0.158 mmol/L; 95% CI: -0.291 to -0.025 mmol/L;P = 0.02). There is no effect of ALA intake on HDL-C (WMD 0.008 mmol/L; 95% CI: -0.018 to 0.034 mmol/L;P = 0.541). Dose-response analysis indicated that 1 g per day increment of ALA was associated with a 0.0016 mmol/L, 0.0071 mmol/L, 0.0015 and 0.0061 mmol/L reduction in TG (95% CI: -0.0029 to -0.0002 mmol/L), TC (95% CI: -0.0085 to -0.0058 mmol/L), HDL-C (95% CI: -0.0020 to -0.0011 mmol/L) and LDL-C (95% CI: -0.0073 to -0.0049 mmol/L) levels, respectively. The effects of ALA intake on TG, TC and LDL-C concentrations were more obvious among Asian participants, and also more obvious on patients with hyperlipidemia or hyperglycemia compared to healthy individuals. Dietary ALA intervention improves blood lipid profiles by decreasing levels of TG, TC, LDL and VLDL-C. Our findings add to the evidence that increasing ALA intake could potentially prevent risk of cardiovascular diseases.

The Antitumor Effects of α-Linolenic Acid

Effect of N-3 and N-6 Unsaturated Fatty Acids on Prostate Cancer (PC-3) and Prostate Epithelial (RWPE-1) Cells in Vitro

Effects of polyunsaturated fatty acids on the growth of gastric cancer cells in vitro

Linoleic Acid Suppresses Colorectal Cancer Cell Growth by Inducing Oxidant Stress and Mitochondrial Dysfunction

Effect of Α-Linolenic Acid on Streptozotocin-Induced Diabetic Retinopathy Indices in Vivo.

The Multifaceted Role of Alpha-Lipoic Acid in Cancer Prevention, Occurrence, and Treatment

Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo

Protective Effect of Alpha-Linolenic Acid on Human Oral Squamous Cell Carcinoma Metastasis and Apoptotic Cell Death

Effects of -Linolenic Acid Intake on Blood Lipid Profiles:A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Down-regulation of malignant potential by alpha linolenic acid in human and mouse colon cancer cells

The review of alpha‐linolenic acid: Sources, metabolism, and pharmacology

Anti-Inflammatory and Pro-Resolving Effects of N-3 PUFA in Cancers: Structures and Mechanisms

Colorectal cancer cell growth inhibition by linoleic acid is related to fatty acid composition changes

Effects of ALA on Mice TM3 Leydig Cell Viability and Relative Gene Expression

Anti-thrombotic Effects of Α-Linolenic Acid Isolated from Zanthoxylum Bungeanum Maxim Seeds

α-Linolenic acid inhibits the migration of human triple-negative breast cancer cells by attenuating Twist1 expression and suppressing Twist1-mediated epithelial-mesenchymal transition

Α-Linolenic Acid Inhibits Human Renal Cell Carcinoma Cell Proliferation Through PPAR-γ Activation and COX-2 Inhibition

Ursolic Acid In Cancer Treatment And Metastatic Chemoprevention: From Synthesized Derivatives To Nanoformulations In Preclinical Studies

Alantolactone, a Sesquiterpene Lactone, Inhibits Breast Cancer Growth by Antiangiogenic Activity Via Blocking VEGFR2 Signaling.

Health Effects of Omega-3 Polyunsaturated Fatty Acids in Common Diseases

Alantolactone attenuates high-fat diet-induced inflammation and oxidative stress in non-alcoholic fatty liver disease